Literature DB >> 16101320

Time trends in the occurrence of major GI cancers in Iran.

Bahareh Yazdizadeh1, Alireza Mosavi Jarrahi, Hossein Mortazavi, Mohammad Ali Mohagheghi, Soroush Tahmasebi, Azin Nahvijo.   

Abstract

OBJECTIVE: The aim of this study was to study the changes in occurrence of esophageal, stomach and colon cancers (cancers of interest) over the last 30 years in Iran.
MATERIAL AND METHODS: Cancer cases referred to two main cancer centers in the country (the Shiraz cancer center and the Tehran cancer center) during last 30 years and published by the two centers were utilized. Morbidity odds ratios (MOR) were used to study trend in the occurrence of each cancer site in each center. For this purpose the cancers of interest were considered as cases; childhood cancers as controls; and calendar year as exposure. A regression line was fitted to morbidity odds ratios over years and the slope of the regression line was considered to indicate the overall trend. MORs and 95% CIs comparing the last five and first five years were computed to measure the magnitude of the change over time. RESULT: The overall trend for esophageal cancer was decrease (slopes = -0.02 for Shiraz and -0.03 for Tehran); for stomach was increase (slopes = 0.04 for Shiraz and 0.08 for Tehran), and for colon cancer was sharp increase (slopes = 0.02 for Shiraz and 0.10 for Tehran). The magnitude of changes showed stomach cancer to increase by 35% in Shiraz (MOR = 1.35 with 95% CI 1.1, 1.65) and 13% in Tehran (MOR = 1.13 with 95% CI 0.96, 1.38), esophageal cancer to decrease by 20% in Shiraz (MOR = 0.82 with 95% CI 0.62, 1.11) and 50% in Tehran (MOR = 0.52 with 95% CI 0.45, 0.60), and colon cancer to increase by 65% in Shiraz (MOR = 1.65 with 95% CI 1.26, 2.16) and 82% in Tehran (MOR = 1.82 with 95% CI 1.52, 2.25).
CONCLUSION: During the last thirty years the occurrence of major GI cancers has changed in Iran with sharp increase in colon cancer, slight to moderate increase in stomach cancer and sharp decrease in esophageal cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16101320

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  25 in total

1.  A 7-Years Retrospective Study of Gastrointestinal Cancers Incidence in the Western Iran.

Authors:  Masood Yasemi; Mohammad Reza Hafezi Ahmadi; Hadi Peyman; Mohammad Rasool Yasemi; Javaher Khajavikhan; Karim Hemati
Journal:  J Clin Diagn Res       Date:  2015-07-01

2.  Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer.

Authors:  P Mokarram; M Zamani; S Kavousipour; F Naghibalhossaini; C Irajie; M Moradi Sarabi; S V Hosseini
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

3.  Rising rates of colorectal cancer among younger Iranians: is diet to blame?

Authors:  S Hessami Arani; M A Kerachian
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

4.  The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line.

Authors:  E Faghihloo; Y Araei; M Mohammadi; H Mirzaei; H R Mohammadi; T Mokhtari-Azad
Journal:  Cancer Gene Ther       Date:  2016-10-21       Impact factor: 5.987

5.  DNMT3B -579 G>T Promoter Polymorphism and the Risk of Gastric Cancer in the West of Iran.

Authors:  Kulsom Ahmadi; Azam Soleimani; Shiva Irani; Aliasghar Kiani; Kourosh Ghanadi; Zahra Noormohamadi; Foroozan Sakinejad
Journal:  J Gastrointest Cancer       Date:  2018-06

6.  Clinical, endoscopic and pathological characteristics of colorectal polyps in elderly patients: Single-center experience.

Authors:  Lei Zhou; Heng Zhang; Shengbin Sun; Manling Huang; Jing Liu; Dan Xu; Min Song; Chenming Sun; Hui Li; Dan Zheng; Yan Fan; Yusheng Liao; Ping Wang; Jie Wu
Journal:  Mol Clin Oncol       Date:  2017-06-01

7.  MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian colorectal cancer patients.

Authors:  Fakhraddin Naghibalhossaini; Pooneh Mokarram; Islam Khalili; Mohammad Vasei; Seyed Vahid Hosseini; Hassan Ashktorab; Mozhgan Rasti; Kourosh Abdollahi
Journal:  Cancer Genet Cytogenet       Date:  2010-03

8.  Clinical predictors of colorectal polyps and carcinoma in a low prevalence region: results of a colonoscopy based study.

Authors:  Yousef Bafandeh; Manoochehr Khoshbaten; Amir-Taher Eftekhar Sadat; Sara Farhang
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

9.  Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status.

Authors:  Pooneh Mokarram; Fakhraddin Naghibalhossaini; Mehdi Saberi Firoozi; Seyed Vahid Hosseini; Ahmad Izadpanah; Heshmetalah Salahi; Seyed Ali Malek-Hosseini; Abdoulrasool Talei; Mehra Mojallal
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

10.  Distinct high-profile methylated genes in colorectal cancer.

Authors:  Pooneh Mokarram; Krishan Kumar; Hassan Brim; Fakhraddin Naghibalhossaini; Mehdi Saberi-firoozi; Mehdi Nouraie; Robert Green; Ed Lee; Duane T Smoot; Hassan Ashktorab
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.